Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Overdose | 8 | 2024 | 1057 | 1.620 |
Why?
|
| Head Injuries, Closed | 2 | 2018 | 238 | 1.010 |
Why?
|
| Acetaminophen | 4 | 2021 | 531 | 0.860 |
Why?
|
| Tranexamic Acid | 1 | 2024 | 166 | 0.760 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 2021 | 59 | 0.740 |
Why?
|
| Point-of-Care Systems | 2 | 2020 | 1096 | 0.710 |
Why?
|
| Reagent Strips | 1 | 2020 | 63 | 0.680 |
Why?
|
| Diltiazem | 1 | 2017 | 108 | 0.570 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2021 | 456 | 0.570 |
Why?
|
| Metoprolol | 1 | 2017 | 97 | 0.550 |
Why?
|
| Intracranial Hemorrhage, Traumatic | 1 | 2017 | 80 | 0.540 |
Why?
|
| Dabigatran | 1 | 2017 | 129 | 0.530 |
Why?
|
| Antithrombins | 1 | 2017 | 184 | 0.520 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2021 | 674 | 0.500 |
Why?
|
| Psychotropic Drugs | 3 | 2023 | 662 | 0.490 |
Why?
|
| Cyclohexenes | 1 | 2015 | 43 | 0.490 |
Why?
|
| Designer Drugs | 1 | 2015 | 109 | 0.430 |
Why?
|
| Long QT Syndrome | 1 | 2017 | 456 | 0.430 |
Why?
|
| Intracranial Hemorrhages | 1 | 2018 | 788 | 0.410 |
Why?
|
| Multiple Organ Failure | 1 | 2015 | 392 | 0.400 |
Why?
|
| Trauma Centers | 3 | 2018 | 2224 | 0.400 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2015 | 338 | 0.370 |
Why?
|
| Monitoring, Physiologic | 1 | 2017 | 1869 | 0.320 |
Why?
|
| Muscarinic Antagonists | 3 | 2020 | 251 | 0.310 |
Why?
|
| Piperidines | 1 | 2015 | 1230 | 0.290 |
Why?
|
| Blood Glucose | 1 | 2020 | 5209 | 0.280 |
Why?
|
| Bronchodilator Agents | 2 | 2020 | 585 | 0.260 |
Why?
|
| Fentanyl | 3 | 2022 | 597 | 0.260 |
Why?
|
| Hydrazines | 2 | 2024 | 160 | 0.250 |
Why?
|
| Emergency Medical Services | 1 | 2017 | 2192 | 0.240 |
Why?
|
| Rhabdomyolysis | 2 | 2018 | 177 | 0.240 |
Why?
|
| Mushroom Poisoning | 1 | 2023 | 48 | 0.220 |
Why?
|
| Agaricales | 1 | 2023 | 38 | 0.220 |
Why?
|
| Electrocardiography | 1 | 2017 | 5602 | 0.220 |
Why?
|
| Poisons | 1 | 2023 | 45 | 0.210 |
Why?
|
| Plant Poisoning | 1 | 2023 | 73 | 0.210 |
Why?
|
| Foodborne Diseases | 1 | 2023 | 77 | 0.210 |
Why?
|
| Poison Control Centers | 1 | 2024 | 199 | 0.210 |
Why?
|
| Transaminases | 2 | 2023 | 202 | 0.200 |
Why?
|
| Carboxyhemoglobin | 1 | 2021 | 84 | 0.190 |
Why?
|
| Culture | 2 | 2016 | 739 | 0.190 |
Why?
|
| Heart Rate | 1 | 2012 | 4593 | 0.180 |
Why?
|
| Leukotriene Antagonists | 1 | 2020 | 76 | 0.180 |
Why?
|
| Substance Abuse Detection | 3 | 2019 | 447 | 0.170 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2017 | 768 | 0.170 |
Why?
|
| Atrial Fibrillation | 2 | 2017 | 3422 | 0.170 |
Why?
|
| Blood Loss, Surgical | 1 | 2024 | 689 | 0.170 |
Why?
|
| Acetylcysteine | 1 | 2021 | 382 | 0.160 |
Why?
|
| Analgesics, Opioid | 4 | 2023 | 4354 | 0.160 |
Why?
|
| Shock | 1 | 2022 | 351 | 0.160 |
Why?
|
| Toxicology | 1 | 2019 | 151 | 0.160 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 256 | 0.150 |
Why?
|
| Cannabis | 2 | 2023 | 1228 | 0.150 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2020 | 1710 | 0.140 |
Why?
|
| Shock, Septic | 1 | 2022 | 556 | 0.140 |
Why?
|
| Creatine Kinase | 1 | 2018 | 450 | 0.140 |
Why?
|
| Buprenorphine | 1 | 2023 | 479 | 0.140 |
Why?
|
| Hydrocodone | 1 | 2016 | 91 | 0.130 |
Why?
|
| Opioid-Related Disorders | 2 | 2023 | 1766 | 0.130 |
Why?
|
| Toxicokinetics | 1 | 2015 | 27 | 0.130 |
Why?
|
| Performance-Enhancing Substances | 1 | 2016 | 49 | 0.120 |
Why?
|
| Anabolic Agents | 1 | 2016 | 128 | 0.120 |
Why?
|
| Occupational Exposure | 1 | 2024 | 1392 | 0.120 |
Why?
|
| Eating | 1 | 2021 | 1414 | 0.120 |
Why?
|
| Emergency Service, Hospital | 6 | 2023 | 6537 | 0.120 |
Why?
|
| Hospitals, University | 1 | 2017 | 705 | 0.120 |
Why?
|
| Hallucinogens | 1 | 2023 | 684 | 0.120 |
Why?
|
| Humans | 32 | 2024 | 707599 | 0.120 |
Why?
|
| Leisure Activities | 1 | 2016 | 320 | 0.110 |
Why?
|
| Nootropic Agents | 1 | 2016 | 280 | 0.110 |
Why?
|
| Cytomegalovirus Infections | 1 | 2022 | 1340 | 0.110 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2014 | 133 | 0.110 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2016 | 405 | 0.110 |
Why?
|
| Prescription Drug Misuse | 1 | 2016 | 185 | 0.110 |
Why?
|
| Treatment Refusal | 1 | 2015 | 335 | 0.100 |
Why?
|
| Psychomotor Agitation | 1 | 2015 | 300 | 0.100 |
Why?
|
| Emergency Treatment | 1 | 2015 | 464 | 0.100 |
Why?
|
| Vasodilator Agents | 1 | 2017 | 1143 | 0.100 |
Why?
|
| Drug Utilization | 1 | 2015 | 729 | 0.100 |
Why?
|
| Asthma | 2 | 2020 | 4690 | 0.100 |
Why?
|
| Athletes | 1 | 2016 | 499 | 0.100 |
Why?
|
| Medical Marijuana | 1 | 2016 | 250 | 0.100 |
Why?
|
| Substance-Related Disorders | 3 | 2016 | 6405 | 0.100 |
Why?
|
| Administration, Inhalation | 3 | 2020 | 1297 | 0.090 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 2016 | 906 | 0.090 |
Why?
|
| Adult | 14 | 2024 | 205108 | 0.090 |
Why?
|
| Data Collection | 1 | 2019 | 3163 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 1886 | 0.090 |
Why?
|
| Fatal Outcome | 1 | 2015 | 1759 | 0.090 |
Why?
|
| Population Surveillance | 1 | 2019 | 2322 | 0.090 |
Why?
|
| Retrospective Studies | 8 | 2024 | 73685 | 0.090 |
Why?
|
| Female | 15 | 2024 | 378021 | 0.090 |
Why?
|
| Military Personnel | 1 | 2021 | 1669 | 0.080 |
Why?
|
| Electric Countershock | 1 | 2012 | 436 | 0.080 |
Why?
|
| Urban Population | 1 | 2017 | 2010 | 0.080 |
Why?
|
| Venous Thrombosis | 1 | 2017 | 1004 | 0.080 |
Why?
|
| Prospective Studies | 4 | 2023 | 41056 | 0.080 |
Why?
|
| Academic Medical Centers | 2 | 2019 | 2446 | 0.080 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2017 | 883 | 0.080 |
Why?
|
| Androgens | 1 | 2016 | 1301 | 0.080 |
Why?
|
| Middle Aged | 10 | 2024 | 201528 | 0.080 |
Why?
|
| Registries | 2 | 2023 | 7827 | 0.080 |
Why?
|
| Drug Users | 1 | 2015 | 675 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 29652 | 0.070 |
Why?
|
| Pulmonary Embolism | 1 | 2017 | 1570 | 0.070 |
Why?
|
| Aged | 7 | 2024 | 154705 | 0.070 |
Why?
|
| Central Nervous System Stimulants | 1 | 2016 | 1478 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 17191 | 0.060 |
Why?
|
| Male | 12 | 2024 | 361235 | 0.060 |
Why?
|
| California | 3 | 2023 | 22893 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2019 | 7168 | 0.060 |
Why?
|
| Tobacco Use Disorder | 1 | 2014 | 1323 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 56287 | 0.060 |
Why?
|
| Drug and Narcotic Control | 2 | 2016 | 181 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 11624 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 6708 | 0.060 |
Why?
|
| Acute Disease | 1 | 2012 | 5510 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2019 | 18861 | 0.050 |
Why?
|
| Milrinone | 1 | 2022 | 57 | 0.050 |
Why?
|
| Naloxone | 2 | 2016 | 675 | 0.050 |
Why?
|
| Hydroxocobalamin | 1 | 2022 | 44 | 0.050 |
Why?
|
| Dobutamine | 1 | 2022 | 197 | 0.050 |
Why?
|
| Vasopressins | 1 | 2022 | 278 | 0.050 |
Why?
|
| Methylene Blue | 1 | 2022 | 167 | 0.050 |
Why?
|
| Incidence | 1 | 2018 | 16041 | 0.050 |
Why?
|
| Aviation | 1 | 2021 | 33 | 0.050 |
Why?
|
| Metered Dose Inhalers | 1 | 2020 | 34 | 0.040 |
Why?
|
| Hospital Mortality | 2 | 2023 | 3953 | 0.040 |
Why?
|
| Thiamine | 1 | 2022 | 206 | 0.040 |
Why?
|
| Prevalence | 1 | 2017 | 16088 | 0.040 |
Why?
|
| Alcoholism | 1 | 2014 | 3401 | 0.040 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2020 | 117 | 0.040 |
Why?
|
| Catheter Ablation | 1 | 2012 | 2498 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 20644 | 0.040 |
Why?
|
| Catecholamines | 1 | 2022 | 807 | 0.040 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2020 | 199 | 0.040 |
Why?
|
| Ascorbic Acid | 1 | 2022 | 551 | 0.040 |
Why?
|
| Vasoconstrictor Agents | 1 | 2022 | 620 | 0.040 |
Why?
|
| Angiotensin II | 1 | 2022 | 766 | 0.040 |
Why?
|
| Cardiotonic Agents | 1 | 2022 | 598 | 0.040 |
Why?
|
| Sentinel Surveillance | 1 | 2019 | 260 | 0.040 |
Why?
|
| Macrolides | 1 | 2020 | 422 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2020 | 942 | 0.030 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2016 | 71 | 0.030 |
Why?
|
| United States | 5 | 2024 | 64343 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 28131 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2020 | 1284 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2020 | 1953 | 0.030 |
Why?
|
| Stroke | 1 | 2017 | 8421 | 0.030 |
Why?
|
| Amphetamines | 1 | 2016 | 167 | 0.030 |
Why?
|
| Hydromorphone | 1 | 2015 | 108 | 0.030 |
Why?
|
| Clonidine | 1 | 2014 | 188 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2019 | 1001 | 0.030 |
Why?
|
| Inpatients | 1 | 2023 | 1808 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 9663 | 0.030 |
Why?
|
| Adolescent | 4 | 2024 | 82906 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 2016 | 957 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2012 | 18593 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2016 | 1960 | 0.020 |
Why?
|
| Dexmedetomidine | 1 | 2014 | 297 | 0.020 |
Why?
|
| Government Regulation | 1 | 2014 | 391 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2015 | 2258 | 0.020 |
Why?
|
| Automobile Driving | 1 | 2016 | 441 | 0.020 |
Why?
|
| Cannabinoids | 1 | 2016 | 433 | 0.020 |
Why?
|
| Child | 3 | 2023 | 65942 | 0.020 |
Why?
|
| Marijuana Abuse | 1 | 2016 | 557 | 0.020 |
Why?
|
| Morphine | 1 | 2015 | 943 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2023 | 34455 | 0.020 |
Why?
|
| Young Adult | 3 | 2024 | 59646 | 0.020 |
Why?
|
| Drug Design | 1 | 2016 | 1732 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2015 | 60305 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2020 | 2643 | 0.020 |
Why?
|
| Perception | 1 | 2014 | 1481 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2016 | 2108 | 0.020 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2016 | 2375 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 15584 | 0.010 |
Why?
|
| Smoking | 1 | 2020 | 7522 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 8103 | 0.010 |
Why?
|
| Infant | 1 | 2019 | 28849 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 16626 | 0.010 |
Why?
|
| Animals | 2 | 2021 | 224480 | 0.010 |
Why?
|